Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

November 01, 1982; Volume 22,Issue 3
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abita, J P

    1. You have access
      Identification and characterization of surface receptors for histamine in the human promyelocytic leukemia cell line HL-60. Comparison with human peripheral neutrophils.
      C Gespach, F Saal, H Cost and J P Abita
      Molecular Pharmacology November 1982, 22 (3) 547-553;
  2. Albuquerque, E X

    1. You have access
      Pumiliotoxin-C and synthetic analogues. A new class of nicotinic antagonists.
      J E Warnick, P J Jessup, L E Overman, M E Eldefrawi, Y Nimit, J W Daly and E X Albuquerque
      Molecular Pharmacology November 1982, 22 (3) 565-573;
    2. You have access
      Meproadifen reaction with the ionic channel of the acetylcholine receptor: potentiation of agonist-induced desensitization at the frog neuromuscular junction.
      M A Maleque, C Souccar, J B Cohen and E X Albuquerque
      Molecular Pharmacology November 1982, 22 (3) 636-647;
  3. Anderson, W

    1. You have access
      Conformational-energy studies of tetrapeptide opiates. Candidate active and inactive conformations.
      G Loew, G Hashimoto, L Williamson, S Burt and W Anderson
      Molecular Pharmacology November 1982, 22 (3) 667-677;
  4. Aslanian, D

    1. You have access
      Inelastic electron tunneling spectroscopic study of interaction of acetylcholine and beta-methyl acetylcholine with alumina surface.
      D Aslanian and S de Cheveigné
      Molecular Pharmacology November 1982, 22 (3) 678-686;

B

  1. Barber, R

    1. You have access
      Differences in the forskolin activation of adenylate cyclases in wild-type and variant lymphoma cells.
      R B Clark, T J Goka, D A Green, R Barber and R W Butcher
      Molecular Pharmacology November 1982, 22 (3) 609-613;
  2. Bend, J R

    1. You have access
      The relationship between the catalytic activities of rabbit pulmonary cytochrome P-450 isozymes and the lung-specific toxicity of the furan derivative, 4-ipomeanol.
      C R Wolf, C N Statham, M G McMenamin, J R Bend, M R Boyd and R M Philpot
      Molecular Pharmacology November 1982, 22 (3) 738-744;
  3. Boyd, M R

    1. You have access
      The relationship between the catalytic activities of rabbit pulmonary cytochrome P-450 isozymes and the lung-specific toxicity of the furan derivative, 4-ipomeanol.
      C R Wolf, C N Statham, M G McMenamin, J R Bend, M R Boyd and R M Philpot
      Molecular Pharmacology November 1982, 22 (3) 738-744;
  4. Brown, O E

    1. You have access
      Metabolic inhibition by a new antifolate, 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methyl-pyrido[2,3-d]pyrimidine (BW3O1U), an effective inhibitor of human lymphoid and dihydrofolate reductase-overproducing mouse cell lines.
      W D Sedwick, M Hamrell, O E Brown and J Laszlo
      Molecular Pharmacology November 1982, 22 (3) 766-770;
  5. Brune, K

    1. You have access
      Quantum chemical analysis of structure-activity relationships in nonsteroidal anti-inflammatory drugs.
      E L Mehler, J Habicht and K Brune
      Molecular Pharmacology November 1982, 22 (3) 525-528;
  6. Burt, S

    1. You have access
      Conformational-energy studies of tetrapeptide opiates. Candidate active and inactive conformations.
      G Loew, G Hashimoto, L Williamson, S Burt and W Anderson
      Molecular Pharmacology November 1982, 22 (3) 667-677;
  7. Butcher, R W

    1. You have access
      Differences in the forskolin activation of adenylate cyclases in wild-type and variant lymphoma cells.
      R B Clark, T J Goka, D A Green, R Barber and R W Butcher
      Molecular Pharmacology November 1982, 22 (3) 609-613;

C

  1. Catterall, W A

    1. You have access
      Inhibition of binding of [3H]batrachotoxinin A 20-alpha-benzoate to sodium channels by the anticonvulsant drugs diphenylhydantoin and carbamazepine.
      M Willow and W A Catterall
      Molecular Pharmacology November 1982, 22 (3) 627-635;
  2. Chwang, T L

    1. You have access
      Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.
      D Roberts, P Franklin, G Odom, C Peck and T L Chwang
      Molecular Pharmacology November 1982, 22 (3) 760-765;
  3. Clark, R B

    1. You have access
      Differences in the forskolin activation of adenylate cyclases in wild-type and variant lymphoma cells.
      R B Clark, T J Goka, D A Green, R Barber and R W Butcher
      Molecular Pharmacology November 1982, 22 (3) 609-613;
  4. Clement-Cormier, Y C

    1. You have access
      Selective effects of an essential sulfhydryl group on the activation of dopamine- and guanine nucleotide-sensitive adenylate cyclase.
      E T Suen, P C Kwan and Y C Clement-Cormier
      Molecular Pharmacology November 1982, 22 (3) 595-601;
  5. Cohen, J B

    1. You have access
      Meproadifen reaction with the ionic channel of the acetylcholine receptor: potentiation of agonist-induced desensitization at the frog neuromuscular junction.
      M A Maleque, C Souccar, J B Cohen and E X Albuquerque
      Molecular Pharmacology November 1982, 22 (3) 636-647;
  6. Collins, A C

    1. You have access
      Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate.
      M J Marks and A C Collins
      Molecular Pharmacology November 1982, 22 (3) 554-564;
  7. Cost, H

    1. You have access
      Identification and characterization of surface receptors for histamine in the human promyelocytic leukemia cell line HL-60. Comparison with human peripheral neutrophils.
      C Gespach, F Saal, H Cost and J P Abita
      Molecular Pharmacology November 1982, 22 (3) 547-553;

D

  1. Daly, J W

    1. You have access
      Pumiliotoxin-C and synthetic analogues. A new class of nicotinic antagonists.
      J E Warnick, P J Jessup, L E Overman, M E Eldefrawi, Y Nimit, J W Daly and E X Albuquerque
      Molecular Pharmacology November 1982, 22 (3) 565-573;
  2. Dannan, G A

    1. You have access
      Immunochemical comparison and quantitation of microsomal flavin-containing monooxygenases in various hog, mouse, rat, rabbit, dog, and human tissues.
      G A Dannan and F P Guengerich
      Molecular Pharmacology November 1982, 22 (3) 787-794;
  3. de Cheveigné, S

    1. You have access
      Inelastic electron tunneling spectroscopic study of interaction of acetylcholine and beta-methyl acetylcholine with alumina surface.
      D Aslanian and S de Cheveigné
      Molecular Pharmacology November 1982, 22 (3) 678-686;
  4. De Lean, A

    1. You have access
      Regulation of insulin receptors in frog erythrocytes by insulin and concanavalin A. Evidence for discrete classes of insulin binding sites.
      R D Vale, A De Lean, R J Lefkowitz and J M Stadel
      Molecular Pharmacology November 1982, 22 (3) 619-626;

E

  1. Eldefrawi, M E

    1. You have access
      Pumiliotoxin-C and synthetic analogues. A new class of nicotinic antagonists.
      J E Warnick, P J Jessup, L E Overman, M E Eldefrawi, Y Nimit, J W Daly and E X Albuquerque
      Molecular Pharmacology November 1982, 22 (3) 565-573;

F

  1. Franklin, P

    1. You have access
      Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.
      D Roberts, P Franklin, G Odom, C Peck and T L Chwang
      Molecular Pharmacology November 1982, 22 (3) 760-765;

G

  1. Gespach, C

    1. You have access
      Identification and characterization of surface receptors for histamine in the human promyelocytic leukemia cell line HL-60. Comparison with human peripheral neutrophils.
      C Gespach, F Saal, H Cost and J P Abita
      Molecular Pharmacology November 1982, 22 (3) 547-553;
  2. Goka, T J

    1. You have access
      Differences in the forskolin activation of adenylate cyclases in wild-type and variant lymphoma cells.
      R B Clark, T J Goka, D A Green, R Barber and R W Butcher
      Molecular Pharmacology November 1982, 22 (3) 609-613;
  3. Green, D A

    1. You have access
      Differences in the forskolin activation of adenylate cyclases in wild-type and variant lymphoma cells.
      R B Clark, T J Goka, D A Green, R Barber and R W Butcher
      Molecular Pharmacology November 1982, 22 (3) 609-613;
  4. Guengerich, F P

    1. You have access
      Immunochemical comparison and quantitation of microsomal flavin-containing monooxygenases in various hog, mouse, rat, rabbit, dog, and human tissues.
      G A Dannan and F P Guengerich
      Molecular Pharmacology November 1982, 22 (3) 787-794;
  5. Gylfe, E

    1. You have access
      Lack of Ca2+ ionophoretic activity of hypoglycemic sulfonylureas in excitable cells and isolated secretory granules.
      E Gylfe and B Hellman
      Molecular Pharmacology November 1982, 22 (3) 715-720;

H

  1. Habicht, J

    1. You have access
      Quantum chemical analysis of structure-activity relationships in nonsteroidal anti-inflammatory drugs.
      E L Mehler, J Habicht and K Brune
      Molecular Pharmacology November 1982, 22 (3) 525-528;
  2. Hamrell, M

    1. You have access
      Metabolic inhibition by a new antifolate, 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methyl-pyrido[2,3-d]pyrimidine (BW3O1U), an effective inhibitor of human lymphoid and dihydrofolate reductase-overproducing mouse cell lines.
      W D Sedwick, M Hamrell, O E Brown and J Laszlo
      Molecular Pharmacology November 1982, 22 (3) 766-770;
  3. Hashimoto, G

    1. You have access
      Conformational-energy studies of tetrapeptide opiates. Candidate active and inactive conformations.
      G Loew, G Hashimoto, L Williamson, S Burt and W Anderson
      Molecular Pharmacology November 1982, 22 (3) 667-677;
  4. Hellman, B

    1. You have access
      Lack of Ca2+ ionophoretic activity of hypoglycemic sulfonylureas in excitable cells and isolated secretory granules.
      E Gylfe and B Hellman
      Molecular Pharmacology November 1982, 22 (3) 715-720;
  5. Hnatowich, M

    1. You have access
      Light-enhanced inhibition of ouabain binding to digitalis receptor in rat brain and guinea pig heart by the food dye erythrosine.
      M Hnatowich and F S LaBella
      Molecular Pharmacology November 1982, 22 (3) 687-692;
  6. Houghton, J A

    1. You have access
      The selectivity of action of methotrexate in combination with 5-fluorouracil in xenografts of human colon adenocarcinomas.
      J A Houghton, A J Tice and P J Houghton
      Molecular Pharmacology November 1982, 22 (3) 771-778;
  7. Houghton, P J

    1. You have access
      The selectivity of action of methotrexate in combination with 5-fluorouracil in xenografts of human colon adenocarcinomas.
      J A Houghton, A J Tice and P J Houghton
      Molecular Pharmacology November 1982, 22 (3) 771-778;

I

  1. Insel, P A

    1. You have access
      Characterization of alpha-adrenergic receptor subtypes in the rat renal cortex. Differential regulation of alpha 1- and alpha 2-adrenergic receptors by guanyl nucleotides and Na.
      M D Snavely and P A Insel
      Molecular Pharmacology November 1982, 22 (3) 532-546;

J

  1. Jessup, P J

    1. You have access
      Pumiliotoxin-C and synthetic analogues. A new class of nicotinic antagonists.
      J E Warnick, P J Jessup, L E Overman, M E Eldefrawi, Y Nimit, J W Daly and E X Albuquerque
      Molecular Pharmacology November 1982, 22 (3) 565-573;
  2. Johnston, C I

    1. You have access
      Characterization of adenylate cyclase-coupled alpha 2-adrenergic receptors in rat renal cortex using [3H]yohimbine.
      E A Woodcock and C I Johnston
      Molecular Pharmacology November 1982, 22 (3) 589-594;
  3. Joost, H G

    1. You have access
      Modulation of insulin sensitivity by adenosine. Effects on glucose transport, lipid synthesis, and insulin receptors of the adipocyte.
      H G Joost and H J Steinfelder
      Molecular Pharmacology November 1982, 22 (3) 614-618;

K

  1. Kaiser, E T

    1. You have access
      Structural characterization of beta-endorphin through the design, synthesis, and study of model peptides.
      J W Taylor, R J Miller and E T Kaiser
      Molecular Pharmacology November 1982, 22 (3) 657-666;
  2. Kloss, M W

    1. You have access
      Initiation of in vitro lipid peroxidation by N-hydroxynorcocaine and norcocaine nitroxide.
      G M Rosen, M W Kloss and E J Rauckman
      Molecular Pharmacology November 1982, 22 (3) 529-531;
  3. Koivusaari, U

    1. You have access
      Increased fluidity of a model membrane caused by tetrahydro-beta-carbolines.
      P Peura, P Mackenzie, U Koivusaari and M Lang
      Molecular Pharmacology November 1982, 22 (3) 721-724;
  4. Kwan, P C

    1. You have access
      Selective effects of an essential sulfhydryl group on the activation of dopamine- and guanine nucleotide-sensitive adenylate cyclase.
      E T Suen, P C Kwan and Y C Clement-Cormier
      Molecular Pharmacology November 1982, 22 (3) 595-601;

L

  1. LaBella, F S

    1. You have access
      Light-enhanced inhibition of ouabain binding to digitalis receptor in rat brain and guinea pig heart by the food dye erythrosine.
      M Hnatowich and F S LaBella
      Molecular Pharmacology November 1982, 22 (3) 687-692;
  2. Lang, M

    1. You have access
      Increased fluidity of a model membrane caused by tetrahydro-beta-carbolines.
      P Peura, P Mackenzie, U Koivusaari and M Lang
      Molecular Pharmacology November 1982, 22 (3) 721-724;
  3. Laszlo, J

    1. You have access
      Metabolic inhibition by a new antifolate, 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methyl-pyrido[2,3-d]pyrimidine (BW3O1U), an effective inhibitor of human lymphoid and dihydrofolate reductase-overproducing mouse cell lines.
      W D Sedwick, M Hamrell, O E Brown and J Laszlo
      Molecular Pharmacology November 1982, 22 (3) 766-770;
  4. Lefkowitz, R J

    1. You have access
      Regulation of insulin receptors in frog erythrocytes by insulin and concanavalin A. Evidence for discrete classes of insulin binding sites.
      R D Vale, A De Lean, R J Lefkowitz and J M Stadel
      Molecular Pharmacology November 1982, 22 (3) 619-626;
  5. Loew, G

    1. You have access
      Conformational-energy studies of tetrapeptide opiates. Candidate active and inactive conformations.
      G Loew, G Hashimoto, L Williamson, S Burt and W Anderson
      Molecular Pharmacology November 1982, 22 (3) 667-677;
  6. Lombardini, J B

    1. You have access
      Differences in the active-site region of tumor versus normal isozymes of mammalian ATP:L-methionine S-adenosyltransferase.
      J R Sufrin and J B Lombardini
      Molecular Pharmacology November 1982, 22 (3) 752-759;
  7. Lucier, G W

    1. You have access
      Endocrine regulation of cadmium-sensitive cytochrome P-450 in rat liver.
      E M Lui, S R Slaughter, R M Philpot and G W Lucier
      Molecular Pharmacology November 1982, 22 (3) 795-802;
  8. Lui, E M

    1. You have access
      Endocrine regulation of cadmium-sensitive cytochrome P-450 in rat liver.
      E M Lui, S R Slaughter, R M Philpot and G W Lucier
      Molecular Pharmacology November 1982, 22 (3) 795-802;
  9. Lukovitz, I

    1. You have access
      A theorem on de novo group contributions.
      I Lukovitz
      Molecular Pharmacology November 1982, 22 (3) 725-731;

M

  1. MacDonald, T L

    1. You have access
      Rat liver microsomal metabolism of propyl halides.
      H Tachizawa, T L MacDonald and R A Neal
      Molecular Pharmacology November 1982, 22 (3) 745-751;
  2. Macfarlane, D E

    1. You have access
      Parallel observation of the occupancy of the alpha 2-adrenergic receptor in intact platelets and its ability to inhibit the adenylate cyclase.
      D E Macfarlane and D C Stump
      Molecular Pharmacology November 1982, 22 (3) 574-579;
    2. You have access
      Bidirectional collision coupling in the regulation of the adenylate cyclase. The allozyme hypothesis for receptor function.
      D E Macfarlane
      Molecular Pharmacology November 1982, 22 (3) 580-588;
  3. Mackenzie, P

    1. You have access
      Increased fluidity of a model membrane caused by tetrahydro-beta-carbolines.
      P Peura, P Mackenzie, U Koivusaari and M Lang
      Molecular Pharmacology November 1982, 22 (3) 721-724;
  4. Maleque, M A

    1. You have access
      Meproadifen reaction with the ionic channel of the acetylcholine receptor: potentiation of agonist-induced desensitization at the frog neuromuscular junction.
      M A Maleque, C Souccar, J B Cohen and E X Albuquerque
      Molecular Pharmacology November 1982, 22 (3) 636-647;
  5. Marks, M J

    1. You have access
      Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate.
      M J Marks and A C Collins
      Molecular Pharmacology November 1982, 22 (3) 554-564;
  6. Mason, R P

    1. You have access
      Direct detection of the sulfur trioxide radical anion during the horseradish peroxidase-hydrogen peroxide oxidation of sulfite (aqueous sulfur dioxide).
      C Mottley, T B Trice and R P Mason
      Molecular Pharmacology November 1982, 22 (3) 732-737;
  7. McMenamin, M G

    1. You have access
      The relationship between the catalytic activities of rabbit pulmonary cytochrome P-450 isozymes and the lung-specific toxicity of the furan derivative, 4-ipomeanol.
      C R Wolf, C N Statham, M G McMenamin, J R Bend, M R Boyd and R M Philpot
      Molecular Pharmacology November 1982, 22 (3) 738-744;
  8. Mehler, E L

    1. You have access
      Quantum chemical analysis of structure-activity relationships in nonsteroidal anti-inflammatory drugs.
      E L Mehler, J Habicht and K Brune
      Molecular Pharmacology November 1982, 22 (3) 525-528;
  9. Miller, R J

    1. You have access
      Structural characterization of beta-endorphin through the design, synthesis, and study of model peptides.
      J W Taylor, R J Miller and E T Kaiser
      Molecular Pharmacology November 1982, 22 (3) 657-666;
  10. Mottley, C

    1. You have access
      Direct detection of the sulfur trioxide radical anion during the horseradish peroxidase-hydrogen peroxide oxidation of sulfite (aqueous sulfur dioxide).
      C Mottley, T B Trice and R P Mason
      Molecular Pharmacology November 1982, 22 (3) 732-737;

N

  1. Neal, R A

    1. You have access
      Rat liver microsomal metabolism of propyl halides.
      H Tachizawa, T L MacDonald and R A Neal
      Molecular Pharmacology November 1982, 22 (3) 745-751;
  2. Nebert, D W

    1. You have access
      Quantitation of hepatic cytochrome P1-450 mRNA with the use of a cloned DNA probe. Effects of various P-450 inducers in C57BL/6N and DBA/2N mice.
      R H Tukey, M Negishi and D W Nebert
      Molecular Pharmacology November 1982, 22 (3) 779-786;
  3. Negishi, M

    1. You have access
      Quantitation of hepatic cytochrome P1-450 mRNA with the use of a cloned DNA probe. Effects of various P-450 inducers in C57BL/6N and DBA/2N mice.
      R H Tukey, M Negishi and D W Nebert
      Molecular Pharmacology November 1982, 22 (3) 779-786;
  4. Nimit, Y

    1. You have access
      Pumiliotoxin-C and synthetic analogues. A new class of nicotinic antagonists.
      J E Warnick, P J Jessup, L E Overman, M E Eldefrawi, Y Nimit, J W Daly and E X Albuquerque
      Molecular Pharmacology November 1982, 22 (3) 565-573;

O

  1. Odom, G

    1. You have access
      Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.
      D Roberts, P Franklin, G Odom, C Peck and T L Chwang
      Molecular Pharmacology November 1982, 22 (3) 760-765;
  2. Overman, L E

    1. You have access
      Pumiliotoxin-C and synthetic analogues. A new class of nicotinic antagonists.
      J E Warnick, P J Jessup, L E Overman, M E Eldefrawi, Y Nimit, J W Daly and E X Albuquerque
      Molecular Pharmacology November 1982, 22 (3) 565-573;

P

  1. Peck, C

    1. You have access
      Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.
      D Roberts, P Franklin, G Odom, C Peck and T L Chwang
      Molecular Pharmacology November 1982, 22 (3) 760-765;
  2. Peura, P

    1. You have access
      Increased fluidity of a model membrane caused by tetrahydro-beta-carbolines.
      P Peura, P Mackenzie, U Koivusaari and M Lang
      Molecular Pharmacology November 1982, 22 (3) 721-724;
  3. Philpot, R M

    1. You have access
      The relationship between the catalytic activities of rabbit pulmonary cytochrome P-450 isozymes and the lung-specific toxicity of the furan derivative, 4-ipomeanol.
      C R Wolf, C N Statham, M G McMenamin, J R Bend, M R Boyd and R M Philpot
      Molecular Pharmacology November 1982, 22 (3) 738-744;
    2. You have access
      Endocrine regulation of cadmium-sensitive cytochrome P-450 in rat liver.
      E M Lui, S R Slaughter, R M Philpot and G W Lucier
      Molecular Pharmacology November 1982, 22 (3) 795-802;

R

  1. Rauckman, E J

    1. You have access
      Initiation of in vitro lipid peroxidation by N-hydroxynorcocaine and norcocaine nitroxide.
      G M Rosen, M W Kloss and E J Rauckman
      Molecular Pharmacology November 1982, 22 (3) 529-531;
  2. Rautanen, P K

    1. You have access
      Pharmacological characterization of histamine receptors mediating cyclic AMP accumulation in the mouse vas deferens. Sensitivity to H1 and H2 receptor agonists and antagonists.
      M M Vohra and P K Rautanen
      Molecular Pharmacology November 1982, 22 (3) 602-608;
  3. Retz, K C

    1. You have access
      Mechanism of inhibition of protein synthesis by morphine in rat brain and liver.
      K C Retz and W J Steele
      Molecular Pharmacology November 1982, 22 (3) 706-714;
  4. Roberts, D

    1. You have access
      Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.
      D Roberts, P Franklin, G Odom, C Peck and T L Chwang
      Molecular Pharmacology November 1982, 22 (3) 760-765;
  5. Rosen, G M

    1. You have access
      Initiation of in vitro lipid peroxidation by N-hydroxynorcocaine and norcocaine nitroxide.
      G M Rosen, M W Kloss and E J Rauckman
      Molecular Pharmacology November 1982, 22 (3) 529-531;

S

  1. Saal, F

    1. You have access
      Identification and characterization of surface receptors for histamine in the human promyelocytic leukemia cell line HL-60. Comparison with human peripheral neutrophils.
      C Gespach, F Saal, H Cost and J P Abita
      Molecular Pharmacology November 1982, 22 (3) 547-553;
  2. Sedwick, W D

    1. You have access
      Metabolic inhibition by a new antifolate, 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methyl-pyrido[2,3-d]pyrimidine (BW3O1U), an effective inhibitor of human lymphoid and dihydrofolate reductase-overproducing mouse cell lines.
      W D Sedwick, M Hamrell, O E Brown and J Laszlo
      Molecular Pharmacology November 1982, 22 (3) 766-770;
  3. Slaughter, S R

    1. You have access
      Endocrine regulation of cadmium-sensitive cytochrome P-450 in rat liver.
      E M Lui, S R Slaughter, R M Philpot and G W Lucier
      Molecular Pharmacology November 1982, 22 (3) 795-802;
  4. Snavely, M D

    1. You have access
      Characterization of alpha-adrenergic receptor subtypes in the rat renal cortex. Differential regulation of alpha 1- and alpha 2-adrenergic receptors by guanyl nucleotides and Na.
      M D Snavely and P A Insel
      Molecular Pharmacology November 1982, 22 (3) 532-546;
  5. Souccar, C

    1. You have access
      Meproadifen reaction with the ionic channel of the acetylcholine receptor: potentiation of agonist-induced desensitization at the frog neuromuscular junction.
      M A Maleque, C Souccar, J B Cohen and E X Albuquerque
      Molecular Pharmacology November 1982, 22 (3) 636-647;
  6. Stadel, J M

    1. You have access
      Regulation of insulin receptors in frog erythrocytes by insulin and concanavalin A. Evidence for discrete classes of insulin binding sites.
      R D Vale, A De Lean, R J Lefkowitz and J M Stadel
      Molecular Pharmacology November 1982, 22 (3) 619-626;
  7. Statham, C N

    1. You have access
      The relationship between the catalytic activities of rabbit pulmonary cytochrome P-450 isozymes and the lung-specific toxicity of the furan derivative, 4-ipomeanol.
      C R Wolf, C N Statham, M G McMenamin, J R Bend, M R Boyd and R M Philpot
      Molecular Pharmacology November 1982, 22 (3) 738-744;
  8. Steele, W J

    1. You have access
      Mechanism of inhibition of protein synthesis by morphine in rat brain and liver.
      K C Retz and W J Steele
      Molecular Pharmacology November 1982, 22 (3) 706-714;
  9. Steinfelder, H J

    1. You have access
      Modulation of insulin sensitivity by adenosine. Effects on glucose transport, lipid synthesis, and insulin receptors of the adipocyte.
      H G Joost and H J Steinfelder
      Molecular Pharmacology November 1982, 22 (3) 614-618;
  10. Stump, D C

    1. You have access
      Parallel observation of the occupancy of the alpha 2-adrenergic receptor in intact platelets and its ability to inhibit the adenylate cyclase.
      D E Macfarlane and D C Stump
      Molecular Pharmacology November 1982, 22 (3) 574-579;
  11. Suen, E T

    1. You have access
      Selective effects of an essential sulfhydryl group on the activation of dopamine- and guanine nucleotide-sensitive adenylate cyclase.
      E T Suen, P C Kwan and Y C Clement-Cormier
      Molecular Pharmacology November 1982, 22 (3) 595-601;
  12. Sufrin, J R

    1. You have access
      Differences in the active-site region of tumor versus normal isozymes of mammalian ATP:L-methionine S-adenosyltransferase.
      J R Sufrin and J B Lombardini
      Molecular Pharmacology November 1982, 22 (3) 752-759;

T

  1. Tachizawa, H

    1. You have access
      Rat liver microsomal metabolism of propyl halides.
      H Tachizawa, T L MacDonald and R A Neal
      Molecular Pharmacology November 1982, 22 (3) 745-751;
  2. Taylor, J W

    1. You have access
      Structural characterization of beta-endorphin through the design, synthesis, and study of model peptides.
      J W Taylor, R J Miller and E T Kaiser
      Molecular Pharmacology November 1982, 22 (3) 657-666;
  3. Tice, A J

    1. You have access
      The selectivity of action of methotrexate in combination with 5-fluorouracil in xenografts of human colon adenocarcinomas.
      J A Houghton, A J Tice and P J Houghton
      Molecular Pharmacology November 1982, 22 (3) 771-778;
  4. Tolkovsky, A M

    1. You have access
      Etorphine binds to multiple opiate receptors of the caudate nucleus with equal affinity but with different kinetics.
      A M Tolkovsky
      Molecular Pharmacology November 1982, 22 (3) 648-656;
  5. Trice, T B

    1. You have access
      Direct detection of the sulfur trioxide radical anion during the horseradish peroxidase-hydrogen peroxide oxidation of sulfite (aqueous sulfur dioxide).
      C Mottley, T B Trice and R P Mason
      Molecular Pharmacology November 1982, 22 (3) 732-737;
  6. Tukey, R H

    1. You have access
      Quantitation of hepatic cytochrome P1-450 mRNA with the use of a cloned DNA probe. Effects of various P-450 inducers in C57BL/6N and DBA/2N mice.
      R H Tukey, M Negishi and D W Nebert
      Molecular Pharmacology November 1982, 22 (3) 779-786;

V

  1. Vale, R D

    1. You have access
      Regulation of insulin receptors in frog erythrocytes by insulin and concanavalin A. Evidence for discrete classes of insulin binding sites.
      R D Vale, A De Lean, R J Lefkowitz and J M Stadel
      Molecular Pharmacology November 1982, 22 (3) 619-626;
  2. Vohra, M M

    1. You have access
      Pharmacological characterization of histamine receptors mediating cyclic AMP accumulation in the mouse vas deferens. Sensitivity to H1 and H2 receptor agonists and antagonists.
      M M Vohra and P K Rautanen
      Molecular Pharmacology November 1982, 22 (3) 602-608;

W

  1. Warnick, J E

    1. You have access
      Pumiliotoxin-C and synthetic analogues. A new class of nicotinic antagonists.
      J E Warnick, P J Jessup, L E Overman, M E Eldefrawi, Y Nimit, J W Daly and E X Albuquerque
      Molecular Pharmacology November 1982, 22 (3) 565-573;
  2. Williamson, L

    1. You have access
      Conformational-energy studies of tetrapeptide opiates. Candidate active and inactive conformations.
      G Loew, G Hashimoto, L Williamson, S Burt and W Anderson
      Molecular Pharmacology November 1982, 22 (3) 667-677;
  3. Willow, M

    1. You have access
      Inhibition of binding of [3H]batrachotoxinin A 20-alpha-benzoate to sodium channels by the anticonvulsant drugs diphenylhydantoin and carbamazepine.
      M Willow and W A Catterall
      Molecular Pharmacology November 1982, 22 (3) 627-635;
  4. Wolf, C R

    1. You have access
      The relationship between the catalytic activities of rabbit pulmonary cytochrome P-450 isozymes and the lung-specific toxicity of the furan derivative, 4-ipomeanol.
      C R Wolf, C N Statham, M G McMenamin, J R Bend, M R Boyd and R M Philpot
      Molecular Pharmacology November 1982, 22 (3) 738-744;
  5. Woodcock, E A

    1. You have access
      Characterization of adenylate cyclase-coupled alpha 2-adrenergic receptors in rat renal cortex using [3H]yohimbine.
      E A Woodcock and C I Johnston
      Molecular Pharmacology November 1982, 22 (3) 589-594;

Y

  1. Yoda, A

    1. You have access
      Formation of ADP-sensitive phosphorylated intermediate in the electric eel Na, K-ATPase preparation.
      A Yoda and S Yoda
      Molecular Pharmacology November 1982, 22 (3) 693-699;
    2. You have access
      Interaction between ouabain and the phosphorylated intermediate of Na,K-ATPase.
      A Yoda and S Yoda
      Molecular Pharmacology November 1982, 22 (3) 700-705;
  2. Yoda, S

    1. You have access
      Formation of ADP-sensitive phosphorylated intermediate in the electric eel Na, K-ATPase preparation.
      A Yoda and S Yoda
      Molecular Pharmacology November 1982, 22 (3) 693-699;
    2. You have access
      Interaction between ouabain and the phosphorylated intermediate of Na,K-ATPase.
      A Yoda and S Yoda
      Molecular Pharmacology November 1982, 22 (3) 700-705;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 22, Issue 3
1 Nov 1982
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Cardiac Safety of Doxorubicin
  • Wnt Signaling and Drug Resistance in Cancer
  • Salicylate Blocks Lipolytic Actions of Tumor Necrosis Factor-α in Primary Rat Adipocytes
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics